These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25775647)

  • 1. Multiple Cutaneous Creamy Papules and Nodules: A Case of Miliarial Gout.
    Kirchhof MG; Collins D; Crawford RI; Au S
    J Cutan Med Surg; 2015; 19(3):317-9. PubMed ID: 25775647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Miliarial gout (a new entity).
    Shukla R; Vender RB; Alhabeeb A; Salama S; Murphy F
    J Cutan Med Surg; 2007; 11(1):31-4. PubMed ID: 17274936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of newly available febuxostat in a case of chronic tophaceous gout contraindicated to allopurinol and probenecid.
    Hilmi BA; Asmahan MI; Rosman A
    Med J Malaysia; 2012 Feb; 67(1):125-6. PubMed ID: 22582566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical Cutaneous Presentation of Chronic Tophaceous Gout: A Case Report.
    Pradhan S; Sinha R; Sharma P; Sinha U
    Indian Dermatol Online J; 2020; 11(2):235-238. PubMed ID: 32477988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Miliarial gout: a rare presentation of extensive cutaneous tophi.
    Hung TL; Wang WM; Chiang CP
    QJM; 2016 Dec; 109(12):811-812. PubMed ID: 27664231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral milia-type intradermal tophi associated with underlying urate subcutaneous deposition: an uncommon cutaneous presentation of gout.
    Aguayo RS; Baradad M; Soria X; Abal L; Sanmartín V; Egido R; Gallel P; Casanova JM; Martí RM
    Clin Exp Dermatol; 2013 Aug; 38(6):622-5. PubMed ID: 23837935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Miliarial Gout Associated with Carpal Tunnel Syndrome: A Very Rare Clinical Presentation.
    Sadovici-Bobeica V; Mazur-Nicorici L; Nicorici A; Şalaru V; Loghin-Oprea N; Garabajiu M; Istrati V; Mazur M
    Eur J Case Rep Intern Med; 2018; 5(9):000926. PubMed ID: 30756065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miliarial gout: Clinical case and a brief review.
    Wei L; Wee CLP; Lee JSS; Wang DY
    Australas J Dermatol; 2022 Feb; 63(1):95-97. PubMed ID: 34905650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulcerated tophaceous gout.
    Ryan MP; Monjazeb S; Goodwin BP; Group AR
    Dermatol Online J; 2019 Mar; 25(3):. PubMed ID: 30982305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of febuxostat treatment in subjects with gout and severe allopurinol adverse reactions.
    Chohan S
    J Rheumatol; 2011 Sep; 38(9):1957-9. PubMed ID: 21724706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated cutaneous gout: a rare manifestation of a common disease.
    Guzman R; DeClerck B; Crew A; Peng D; Adler BL
    Dermatol Online J; 2020 Jan; 26(1):. PubMed ID: 32155023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic biopsy sampling of tophaceous gout of the odontoid process. Case report and review of the literature.
    Fraser JF; Anand VK; Schwartz TH
    J Neurosurg Spine; 2007 Jul; 7(1):61-4. PubMed ID: 17633489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Febuxostat: new drug. Hyperuricaemia: risk of gout attacks.
    Prescrire Int; 2009 Apr; 18(100):63-5. PubMed ID: 19585722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
    Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Eustace D; Palo WA; Streit J; Joseph-Ridge N
    N Engl J Med; 2005 Dec; 353(23):2450-61. PubMed ID: 16339094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Febuxostat efficacy in allopurinol-resistant tophaceous gout.
    Uh M; Reid G
    J Clin Rheumatol; 2011 Jun; 17(4):204-6. PubMed ID: 21617552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.
    Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C
    Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant Tophaceous Gout: The Importance of Therapeutic Compliance.
    Silva Veiga R; Mesquita IB; Gomes da Cunha J; Fonseca JPM; Pereira S
    Cureus; 2024 Feb; 16(2):e54464. PubMed ID: 38510881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Febuxostat for gout.
    Drug Ther Bull; 2010 Jul; 48(7):78-82. PubMed ID: 20631196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gout nodulosis: widespread subcutaneous deposits without gout.
    Iglesias A; Londono JC; Saaibi DL; Peña M; Lizarazo H; Gonzalez EB
    Arthritis Care Res; 1996 Feb; 9(1):74-7. PubMed ID: 8945116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tophi as first clinical sign of gout.
    Thissen CA; Frank J; Lucker GP
    Int J Dermatol; 2008 Nov; 47 Suppl 1():49-51. PubMed ID: 18986488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.